Evidence map›Paper›PMID 30523172›Full record

ArticleArchives of disease in childhood2019

High prevalence of infection and low incidence of disease in child contacts of patients with drug-resistant tuberculosis: a prospective cohort study.

Helena Huerga, Elisabeth Sanchez-Padilla, Nara Melikyan, Hakob Atshemyan, Armen Hayrapetyan, Ani Ulumyan, Mathieu Bastard, Naira Khachatryan, Catherine Hewison, Francis Varaine and 1 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Archives of disease in childhood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Efficacy and safety profile of 2Pakistan journal of medical sciences · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Testing and Scaling Interventions to Improve the Tuberculosis Infection Care Cascade.Journal of the Pediatric Infectious Diseases Society · 2022
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 5 countries.

Helena Huerga *Epicentre, Paris, France.
Elisabeth Sanchez-Padilla *Epicentre, Paris, France.
Nara MelikyanEpicentre, Paris, France.
Hakob AtshemyanMédecins Sans Frontières, Yerevan, Armenia.
Armen HayrapetyanNational Tuberculosis Control Centre, Yerevan, Armenia.
Ani UlumyanNational TB Center in Abovyan, Yerevan, Armenia.
Mathieu BastardEpicentre, Paris, France.
Naira KhachatryanMédecins Sans Frontières, Yerevan, Armenia.
Catherine HewisonMédecins Sans Frontières, Paris, France.
Francis VaraineMédecins Sans Frontières, Paris, France.
Maryline BonnetEpicentre, Paris, France.
Epicentre (South Africa) · ZAMédecins Sans Frontières‎ · GBMédecins Sans Frontières · FRNational Tuberculosis Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to measure the prevalence and incidence of latent tuberculosis infection (LTBI) and tuberculosis (TB) disease in children in close contact with patients with drug-resistant TB (DR-TB) in a country with high DR-TB prevalence. DESIGN AND

settingThis is a prospective cohort study of paediatric contacts of adult patients with pulmonary DR-TB in Armenia. Children were screened using tuberculin skin test, interferon-gamma release assay and chest X-ray at the initial consultation, and were reassessed every 3-6 months for a period of 24 months. Children did not receive preventive treatment.

main outcome measuresPrevalence and incidence of LTBI and TB disease; factors associated with prevalent LTBI.

resultsAt initial evaluation, 3 of the 150 children included were diagnosed with TB disease (2.0%). The prevalence of LTBI was 58.7%. The incidence of LTBI was 19.9 per 100 children per year, and was especially high during the first 6 months of follow-up (33.3 per 100 children per year). No additional cases with incident disease were diagnosed during follow-up. After adjustment, prevalent LTBI was significantly associated with the child's age, sleeping in the same house, higher household density, the index case's age, positive smear result and presence of lung cavities.

conclusionsChildren in close contact with patients with DR-TB or in contact with very contagious patients had an increased risk of prevalent LTBI. Although none of the children developed TB disease during a 2-year follow-up period, screening for symptoms of TB disease, based on the prevalence of disease at recruitment, together with follow-up and repeated testing of non-infected contacts, is highly recommended in paediatric contacts of patients with DR-TB.

Indexed as

AdultArmeniaChildChild, PreschoolFemaleHumansIncidenceInfantInfant, NewbornLatent TuberculosisMaleMiddle AgedPrevalenceProspective StudiesTuberculosis, Multidrug-Resistantdrug-resistanceepidemiologyinfectious diseasesscreeningtuberculosis

Identifiers

PMID30523172
PMCPMC6589461
OpenAlexW2905003824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.